Mary Stafford

CureSearch for Children's Cancer

For more than 30 years, CureSearch has been a driving force in pediatric cancer research. Recognizing a broken system, growing obstacles, and unmet needs in drug development, we've launched an innovative and unique strategy to address the urgent, critical need for new childhood cancer treatments. By supporting CureSearch, you're funding research that's on the path to quickly becoming a drug accessible to the children who so desperately need new treatment options, and you're providing innovative platforms that allow stakeholders to work smarter, faster and more collaboratively. With the expert leadership of our Scientific and Industry Advisory Councils, we identify and fund only the strongest research projects that address areas of unmet need and are most likely to quickly reach patients in the clinic or marketplace. We create connections and community between stakeholders by providing platforms for engagement to allow critical conversations to occur. CureSearch stakeholder meetings such as the annual CureSearch Summit and first-of-its-kind IMPACT Series directly influence and advance pediatric cancer research and drug development. Together, we're changing the drug development landscape from within and accelerating the development of new treatments for the 42 children diagnosed with cancer each day.